| 发明名称 |
(r)-3-(e)-2-(pirrolidin-33-il)vinil)-5-(tetra-hidropiran-4-ilóxi)piridina, seus sais, suas sínteses e seus usos como ligantes para receptores acetilcolinérgico nicotínicos |
| 摘要 |
The present invention relates to the hemi-galactarate, oxalate and di-p-toluoyl-D-tartrate salt forms of (R)-3-((E)-2-(pyrrolidin-3-yl)vinyl)-5-(tetrahydropyran-4-yloxy)pyridine or hydrates or solvates thereof, compositions comprising these salt and their use for treating or preventing a NNR mediated disorder. |
| 申请公布号 |
BRPI0922630(A2) |
申请公布日期 |
2016.01.05 |
| 申请号 |
BR2009PI22630 |
申请日期 |
2009.11.30 |
| 申请人 |
TARGACEPT, INC |
发明人 |
DANIEL YOHANNES;GARY MAURICE DULL;GREGORY J. GATTO;JOHN GENUS;JOSEPH PIKE MITCHENER, JR.;JULIO A. MUNOZ;NIKOLAI FEDOROV;PHILIP S. HAMMOND;PIETER ALBERT OTTEN;SCOTT R. BREINING;SRINIVISA RAO AKIREDDY;TIMOTHY J. CUTHBERTSON |
| 分类号 |
C07D405/14;A61K31/4439;A61P25/00 |
主分类号 |
C07D405/14 |
| 代理机构 |
|
代理人 |
|
| 主权项 |
|
| 地址 |
|
